Log In
BCIQ
Print this Print this
 

Leuko64

  Manage Alerts
Collapse Summary General Information
Company Trillium Diagnostics LLC
DescriptionAssay for use on multi-parameter flow cytometers that measures CD64 expression
Molecular Target Fc gamma receptor I (FCGR1) (CD64)
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsDiagnose sepsis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$15.0M

$1.5M

$9.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/28/2015

$15.0M

$1.5M

$9.5M

Get a free BioCentury trial today